Skip to main content
Clinical Trials/JPRN-jRCT2080224161
JPRN-jRCT2080224161
Completed
未知

An exploratory clinical trial to evaluate the efficacy and safety of the CCI Kit in patients with knee joint cartilage defects.

Interstem CO .,Ltd0 sites36 target enrollmentNovember 26, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Traumatic cartilage defect of the knee joint and osteochondritis dissecans
Sponsor
Interstem CO .,Ltd
Enrollment
36
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 26, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Interstem CO .,Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\)Patients diagnosed with traumatic cartilage defect of the knee joint and osteochondritis dissecans
  • 2\)Patients applying microfractures
  • 3\)Patients with clinical symptoms in the knee joint
  • 4\)Patients with KOOS 5 of 70 or less at screening
  • 5\)Patients with a cartilage defect area from 2 cm2 to 9 cm2

Exclusion Criteria

  • 1\)Patients diagnosed with osteoarthritis and patients with Kellgren\-Lawrence classification stage 2 or higher
  • 2\)Patients with inflammatory arthritis associated with autoimmune diseases such as rheumatoid arthritis
  • 3\)Patients with cartilage defect in both knee joints
  • 4\)Patients with multiple cartilage defect
  • 5\)Patients with a bone defect with a depth of 8 mm or more at the cartilage defect site
  • 6\)Patients who have a history of surgery for adjustment of joint alignment or who need it

Outcomes

Primary Outcomes

Not specified

Similar Trials